EPISODE · Mar 3, 2023 · 1H 6M
Episode 50
from Biotech Hangout · host Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
This week, Paul Hastings, Chief Executive Officer and President of Nkarta Therapeutics and Chair of the Biotechnology Innovation Organization (BIO), joins Biotech Hangout hosts Daphne Zohar, Josh Schimmer, Rob Perez and Dawn Bell. The group discusses the latest biotech industry consolidations and dissolutions and Big Pharma’s looming patent cliff. They touch on controversies surrounding Vertex’s latest drug pricing, the abortion pill ban and pending implications for the FDA, industry diversity and Vivek Ramaswamy’s resignation from Roivant’s Board of Directors as he prepares to pursue his U.S. presidential campaign.
NOW PLAYING
Episode 50
No transcript for this episode yet
Similar Episodes
May 12, 2026 ·36m
May 11, 2026 ·11m
May 11, 2026 ·34m
May 11, 2026 ·38m